CYTK — CYTOKINETICS INC catalysts
Next verified catalyst
2026-09-01 — AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and · official source ↗
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-09 (month) in 2mo
ESTIMATED |
READOUT
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of S
Phase 2 · Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF) |
CYTK CYTOKINETICS INC | CK-4021586 (150 mg, 300 mg, 450 mg, and |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|